WIXOM, Mich., Oct. 1, 2009 (GLOBE NEWSWIRE) -- Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, today announced that Robert Chioini, Chief Executive Officer, along with Dr. Ajay Gupta, Chief Scientific Officer, will present at the JMP Securities Healthcare Focus Conference at the Palace Hotel in New York.
